↓ Skip to main content

Treatment of depression and anxiety with internet-based cognitive behavior therapy in patients with a recent myocardial infarction (U-CARE Heart): study protocol for a randomized controlled trial

Overview of attention for article published in Trials, April 2015
Altmetric Badge

Mentioned by

twitter
3 X users
facebook
2 Facebook pages

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
242 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treatment of depression and anxiety with internet-based cognitive behavior therapy in patients with a recent myocardial infarction (U-CARE Heart): study protocol for a randomized controlled trial
Published in
Trials, April 2015
DOI 10.1186/s13063-015-0689-y
Pubmed ID
Authors

Fredrika Norlund, Erik MG Olsson, Gunilla Burell, Emma Wallin, Claes Held

Abstract

Major depression and depressive symptoms are common in patients with a recent myocardial infarction (MI), and depression is associated with adverse cardiovascular outcomes. Anxiety post-MI is less studied, but occurs commonly in patients with heart disease, and is also considered a risk factor for recurrence of cardiac events. Cognitive behavior therapy (CBT) is an established therapy for depression and anxiety disorders. To the best of our knowledge, there have not been any studies to determine if internet-based CBT (iCBT) can reduce the symptoms of depression and anxiety in patients with a recent MI. The main aim of the U-CARE Heart trial is to evaluate an iCBT intervention for patients with a recent MI. This is a randomized, controlled, prospective study with a multicenter design. A total of 500 participants will be randomized at a 1:1 ratio, around two months after an acute MI, to either iCBT or to a control group. Both groups will receive an optimal standard of care according to guidelines. The intervention consists of a self-help program delivered via the internet with individual online support from a psychologist. Treatment duration is 14 weeks. The primary outcome is change in patients' self-rated anxiety and depression symptoms from baseline to end of treatment. An internal pilot study was conducted indicating sufficient levels of study acceptability and engagement in treatment. The present study is designed to evaluate an iCBT intervention targeting symptoms of depression and anxiety in a post-MI population. If effective, iCBT has several advantages, and will potentially be implemented as an easily accessible treatment option added to modern standard of care. This trial was registered with Clinicaltrials.gov (identifier: NCT01504191 ) on 19 December 2011.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 242 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Sweden 1 <1%
Switzerland 1 <1%
Unknown 240 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 53 22%
Student > Bachelor 28 12%
Student > Ph. D. Student 27 11%
Researcher 26 11%
Student > Doctoral Student 19 8%
Other 38 16%
Unknown 51 21%
Readers by discipline Count As %
Psychology 73 30%
Medicine and Dentistry 44 18%
Nursing and Health Professions 27 11%
Social Sciences 12 5%
Computer Science 9 4%
Other 21 9%
Unknown 56 23%